CTOs on the Move

CCBR-SYNARC

www.synarc.com

 
Synarc enables its clients to demonstrate the efficacy of new therapies across a broad range of therapeutic areas through highly specialized medical imaging and molecular marker techniques.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.synarc.com
  • 7707 Gateway Blvd
    Newark, CA USA 94560-1085
  • Phone: 415.817.8900

Executives

Name Title Contact Details

Similar Companies

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.

BL Software Systems/BL Healthcare

BL Software Systems/BL Healthcare is a Foxborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Whip Mix Corp.

Whip Mix is the one resource that helps the Dental Profession achieve its goals of high quality, less invasive patient care, reduced chair time and increased operating efficiencies.

Genairex

Genairex is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Palodex

PaloDEx Group Oy operates in the international healthcare market, focusing on X-ray technology applications used in dental imaging. By offering high-quality imaging solutions that help in making the correct treatment decisions and in improving the level